drugset / Trial / NCT06101420
Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This trial assessed the efficacy of potassium competetor acid blocker (P-CAB) in the eradication of H.pylori
Timeline
- Start
- 2022-01-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 20 mg | — |
| Subject | Vonoprazan | Other / unclassified | 20 mg | — |
| Background | Amoxicillin | Other / unclassified | 100 mg | — |
| Background | Amoxicillin | Other / unclassified | 1 g | — |
| Background | Clarithromycin | Small molecule | 500 mg | — |
| Background | Levofloxacin | Small molecule | 500 mg | — |
| Background | Nitazoxanide | Other / unclassified | 500 mg | — |
Indications
No indication recorded.